Sandoz Family Pares Novartis Stake With $2.9 Billion Sale
Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...
Sandoz Family to Get $2.9 Billion From Offloading Part of Its Novartis Stake
ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...
Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
Avecho Biotechnology Limited (ASX: AVE) ("Avecho" or the "Company") today announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG ("Sandoz") for the ...
Sandoz family foundation offers $3 billion worth of Novartis shares
Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss ...
Avecho Biotechnology: Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho ...
NOLA.com6h
The Rex court will watch the parade from a new spot this year, sporting a rainbow of shades
When Rex, the king of Carnival, majestically rolls from his den on South Claiborne Avenue and turns down Napoleon Avenue, the ...
Sandoz Group Ltd (SDZXF) Receives a Hold from UBS
In a report released today, Harry Sephton from UBS maintained a Hold rating on Sandoz Group Ltd (SDZXF – Research Report), with a price target ...
EconoTimes5d
Sandoz Family’s Emasan AG Sells Novartis Stake for $2.9 Billion in Major Cash-Out
Emasan AG, the investment arm of the Sandoz family, has sold a significant stake in Swiss pharmaceutical giant Novartis ...
Reuters5d
Sandoz family to get $2.9 billion from offloading part of its Novartis stake
ZURICH, Feb 26 (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis (NOVN.S), opens new tab ...
Sandoz Family to Sell $2.9 Billion Stake in Novartis
(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.
Aspen Pharmacare's strong interim earnings boosts the share price by 10.6%
Aspen Pharmacare's share price surged by 10. 6% following robust financial results for the first half of the 2025 financial ...
Reuters6d
Sandoz family foundation offers $3 billion worth of Novartis shares
ZURICH, Feb 25 (Reuters) - Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 ...